U.S. Telehealth Market Hits $2.83 Billion By 2022: Grand View Research, Inc.

 

U.S. telehealth market is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.

us-telehealth-market.png
U.S. telehealth market, by product, 2012-2022 (USD Million)

The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.

Also, rising geriatric population requires round-the-clock monitoring in homes as they are prone to various chronic ailments. Telehealth system reduces hospital visits and re-hospitalization of patients, along with round-the-clock remote monitoring and allows patients to recover within the comforts of their own home. Telehealth and tele-monitoring devices tender numerous benefits to cater to these demands and hence propel market growth.

Browse full research report on U.S. Telehealth Market: www.grandviewresearch.com/industry-analysis/us-telehealth-market  

Further Key Findings From the Study Suggest:

  • Hardware segment are expected to account for over 40.0% market share by 2022 owing to, video memory, general memory, internet connection and emailing feature, processor speed and display quality are expected to boost the market growth.
  • Software segment is expected to grow at a lucrative CAGR of over 18.0% during the forecast period. The adoption rate for integrated software is higher as compared to the standalone software due to higher options and applications along with cost-efficiency. Examples of integrated solutions include examination cameras, connected devices and software, and telehealth stations.
  • Key players of this market include Philips Healthcare, GE Healthcare, Bosch Healthcare, Intel, IBM and McKesson Corporation.
  • Market participants are involved in manufacturing wide range of telehealth services and software that can be used for patient monitoring, self care and post op monitoring.
  • For instance, in May 2015, Philips announced that the joint program between Philips Telehealth and Banner Health helped reduce costs by 27% and hospitalizations by 45%. The pilot at-home program was used on patients suffering with critical illnesses that accounted for 50% of the healthcare spending.
  • In August 2015, McKesson Technology Solutions through their RelayHealth unit launched the ICD10Central.com. The platform offers easier collaboration between payers and providers. It also has feature of online forums to promote social media communication and quick responses to billing queries by the providers.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it                               

Grand View Research has segmented the U.S. telehealth market on the basis of products, delivery mode and end-use:

U.S. Telehealth Product Outlook (Revenue, USD Million, 2012 – 2022)

  • Hardware
    • Monitors
    • Medical peripheral devices
      • Blood pressure meters
      • Blood glucose meters
      • Weighing scales
      • Pulse oximeters
      • Peak flow meters
      • ECG monitors
      • Others
    • Software
      • Standalone software
      • Integrated software
    • Services
      • Remote patient monitoring
      • Real-time interactions
      • Store and Forward
      • Other services

U.S. Telehealth Delivery Mode Outlook (Revenue, USD Million, 2012 – 2022)

    • Web-based
    • Cloud-based
    • On-premise based

U.S. Telehealth End-use Outlook (Revenue, USD Million, 2012 – 2022)

    • Providers
    • Payers
    • Others

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/us-telehealth-market-analysis                                                                  

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Advertisements

Teleradiology Market Is Predicted To Grow Swiftly Due To Newly Engineered Digital Technology Till 2024: Grand View Research, Inc.

 

The global teleradiology market is expected to reach over USD 8.24 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technology-enabled, accurate, and real-time medical imaging devices favor their application in hospitals, particularly for emergency cases. Moreover, new digital technology systems facilitate the timely intervention of specialists from different locations for critical cases. The rising base of geriatric population coupled with the increasing prevalence of diseases, such as bone injuries, cancer, and dental problems, drives the need for medical imaging systems. This is expected to have a positive impact on the teleradiology market.

In rural areas, there is a dearth of specialized radiologists in hospitals and majority of the hospitals lack adequate access to the latest medical facilities; hence, these areas serve as a huge base of untapped opportunities. The increasing government initiatives to encourage the use of teleradiology in clinics and hospitals in emergency situations are expected to augment the growth of the teleradiology market.

teleradiology-market.png
Europe teleradiology market share, by product, 2013 – 2024 (USD Million)

Benefits associated with teleradiology are the factors likely to accelerate the market growth over the forecast period. One of the most crucial benefits of teleradiology is getting a spur-of-the-moment, second consultative opinion for critical cases with high-resolution images, which can be sent across the globe to reputed domain-specialists in radiology, thus facilitating a good connectivity among radiologists worldwide. Furthermore, outsourcing of radiology services can be done for small-scale hospitals or hospitals in under-served communities, where the interpretation of reports can be obtained as and when required.

Browse full research report on Teleradiology Market: www.grandviewresearch.com/industry-analysis/teleradiology-market

Further Key Findings From the Study Suggest:

  • The x-ray segment dominated the market in 2015 due to its wide range of applications, such as the detection of fractures in bones or dental injuries and the increasing demand for core diagnostics and bedside imaging. In 2015, this segment occupied over 30.0 % of the revenue share.
  • The teleradiology-based CT scan is the fastest growing segment and is expected to grow at a CAGR of over 20.0% over the forecast period. Its lucrative growth is attributed to the teleradiology-associated advantages, which include a high-resolution imaging capacity, a faster testing rate, high usage rates, and the introduction of new generation models, such as 3D and 4D.
  • In 2015,North America dominated the teleradiology market owing to the existence of an advanced healthcare IT, the introduction of high-speed connections, and high penetration rates of new technologies
  • Supportive government regulations for the expansion of teleradiology and faster technology adoption in Asia Pacific are expected to drive the demand for teleradiology over the forecast period
  • Key players include Agfa-Gevaert N.V., Virtual Radiologic (vRAD), ONARD, Everlight Radiology,Global Diagnostics, 4ways Healthcare Ltd., Spectra AB, Health Watch Tele Diagnostics Pvt. Ltd., and RamSoft, Inc.
  • In an attempt to register significant growth, market players adopted several strategies such as geographic expansions, partnerships, new product development, and acquisitions. For instance, in April 2016, Agfa Healthcare signed an agreement with Derby Teaching Hospitals to implement its ORBIS ICU manager service.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the teleradiology market on the basis of product and region:

Global Teleradiology Product Outlook, by Revenue (USD Million, 2013–2024)

  • X-ray
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Computed Tomography (CT)
  • Nuclear Imaging

Teleradiology Regional Outlook, by Revenue (USD Million, 2013–2024)

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • Japan
  • Latin America
  • Brazil
  • MEA
  • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-teleradiology-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Healthcare Payer BPO Market Is Projected To Grow Rapidly Due To Increase In Geriatric Population Till 2025: Grand View Research, Inc.

 

Global healthcare payer BPO market is expected to reach over USD 34.2 billion by 2022 according to a new report by Grand View Research Inc. Key drivers attributing to the growth are ObamaCare, shift to ICD-10 coding system, growing geriatric population, increasing disease burden and penetration of insurance coverage in emerging economies.

In 2013, as per estimates published by the America’s Health Insurance Plans (AHIP), which is the national trade association representing the health insurance industry, one-sixth of the U.S. economy or nearly USD 2.7 trillion is dedicated to healthcare spending and the number is expected to increase year on year. However, the healthcare system is not able to reap the benefits of such expenditure due to process inefficiencies and use of redundant systems. The estimated loss due to such inefficiencies is nearly 800 billion or approximately 20 to 30 percent of the overall expenditure.

Increasing healthcare expenditure is a major concern for the U.S. and all the other major economies. In order to reduce the economic burden and provide universal access to healthcare, governments are encouraging outsourcing of payer services to onshore or offshore locations.

healthcare-payer-bpo-market.png
North America payer BPO market by type of service, 2012 – 2022 (USD Billion)

The shift from ICD-9 coding system to ICD-10 coding has created huge work load for the payers to upgrade their systems, train their staff and has significantly increased the financial burden. The ICD-9 code system had 13,000 codes, where as the ICD-10 code system has nearly 68,000 codes. This shift from the legacy system to the latest system has significantly increased the need for medical coding, accounting, HR, and other technical professionals, thereby is expected to positively reinforce the healthcare payer BPO outsourcing market growth in the next seven years.

Browse full research report on Healthcare Payer BPO Market: www.grandviewresearch.com/industry-analysis/healthcare-payer-bpo-market

Further key findings from the report suggest:

  • In 2014, claims processing services accounted for the maximum share of approximately 55%. Key reasons attributed are growth in new member enrolments due to ObamaCare, increase in disease burden. For instance, as per data published by ObamaCare and CMS, in 2013 nearly 8 million people enrolled through the marketplace and nearly 11.7 million people were enrolled in 2015.
  • However, Asia Pacific is expected to be the fastest growing market over the forecast period owing to high economic development in the region, favorable government initiatives and growth in insurance penetration across urban and rural centers. For instance, the Indian government’s initiatives such as Pradhan Mantri Suraksha Bima Yojana and Pradhan Mantri Jeevan Jyoti Bima Yojana, are expected to benefit millions of people seeking life insurance and personal accident coverage and as consequence is expected to contribute to the healthcare payer BPO market expansion over the forecast period.
  • Some key players operating in the market include, Xerox Corporation, Genpact Limited, Wipro Limited, Capgemini, Hinduja Global Solutions, HCL Technologies Ltd, Cognizant Technology Solutions, EXLService Holdings Inc., and Accenture. These players dominate the market owing to their strong product and service delivery portfolio, and presence of large customer base in the U.S and European markets.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it                                 

Grand View Research has segmented the Healthcare payer BPO market on the basis of services and region:

Global Healthcare Payer BPO Services Outlook (USD Million, 2015 – 2022)

  • Claims Processing Services
  • Member Services
  • HR Services
  • Finance And Accounts

Healthcare Payer BPO Regional Outlook, (USD Million, 2015 – 2022)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • India
    • China
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-healthcare-payer-bpo-market                                        

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Boosting Demand Of Medical Carts Market Due To Increase In Adoption Of Electronic Medical Record Systems & Mobile Carts Till 2025.

 

The global medical carts market is expected to reach USD 4.55 billion by 2025 by exhibiting a CAGR of 15.2% during the forecast period, according to a new report by Grand View Research, Inc. Increase in adoption of electronic medical records (EMR) in hospitals is expected to drive the medical carts market. The growth of the market can also be attributed to increasing demand for efficient care delivery and patient engagement solutions in healthcare facilities.

us-medical-carts-market.png

Rising incidence of work-related musculoskeletal injury (MSI) among medical and nursing staff is anticipated to propel the demand for mobile medical carts over the forecast period. Furthermore, advancements in clinical workstations such as battery-powered systems with locking drawers and touchscreen communication channels are contributing to the increase in demand for these products over the forecast period.

Browse full research report on Medical Carts Market: www.grandviewresearch.com/industry-analysis/medical-carts-market    

Further key findings from the report suggest:

  • By product, mobile computing carts accounted for the largest share in 2016 owing to increased application in healthcare facilities, such as medical documentation, equipment delivery, dispensing of drugs, and telehealth services
  • Mobile computing carts can be powered and nonpowered. The powered segment is expected to witness lucrative growth in the coming years due to benefits such as portability
  • By type, emergency carts held the majority in 2016 owing to various technological advancements such as improved mobility, lighter weight designs, and enhanced ergonomics
  • Hospitals are the largest end users of medical carts. This can be attributed to increasing incidence of work-related MSIs among hospital staff and spread of infectious diseases
  • Companies are focusing on product launches and innovation to cater to differentiated demand from consumers. They are also offering cost-efficient care delivery solutions to stay ahead
  • For instance, in October 2015, Ergotron, Inc. launched the SV10 series of Styleview Medical Carts to improve its revenue share.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare-it                              

\Grand View Research has segmented the medical carts market on the basis of the product, type, end use, and region:

Medical Carts Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Mobile Computing Carts
    • By Application
      • Medical Documentation
      • Medical Equipment
      • Medication Delivery
      • Telehealth Workstation
      • Others
    • By Energy Source
      • Powered
      • Nonpowered
  • Wall-mounted Workstations
  • Medication Carts
  • Medical Storage Columns, Cabinets, & Accessories
  • Others

Medical Carts Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Anesthesia
  • Emergency
  • Procedure
  • Others

Medical Carts End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Ambulatory Surgical Centers
  • Physician Offices or Clinics
  • Others

Medical Carts Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-medical-carts-market                                  

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Biosimulation Market Is Likely To Reach USD 3.77 Billion By 2024: Grand View Research, Inc.

 

The biosimulation market is expected to reach USD 3.77 billion by 2024, according to a new study by Grand View Research, Inc. The unprecedented global shift in the adoption of unhealthy lifestyles is resulting in the high prevalence of chronic diseases, such as cancer and diabetes, is expected to drive the biosimulation market during the forecast period. In addition, the rising geriatric population base highly susceptible to acquire the aforementioned chronic diseases result in enhanced demand for highly efficacious pharmacological drugs. This high requirement of efficacious drugs can be effectively met at a faster rate through the incorporation of the in silico approach, thus creating a high potential for biosimulation market growth opportunities in the future.

Furthermore, increasing drug resistance, high drug failure rate, and availability of limited drugs to treat several diseasessuch as AIDS, pneumonia, tuberculosis, and others indicate the indisputable requirement for the incorporation of biosimulation in the drug discovery and development process. The widespread application of the in silico approach to developing efficacious drugs would generate drugs of greater potency in the market within a shorter span.

biosimulation-industry
North America Biosimulation Market Share, by Application, 2014 – 2024 (USD Million)

The increasing demand can be attributed primarily to the significant cost reduction in the clinical trials and drug development & discovery process. This is due to the fact that the in silico software can predict adverse reactions, toxicity, and efficacy of the drugsin the early stages of the drug development, thereby reducing the probability of drug failure at the later stages and consequentially, control the overall expenditure. These above-mentioned factors serve as key reasons responsiblefor the heightened market demand.

Browse full research report on Biosimulation Market: https://www.grandviewresearch.com/industry-analysis/biosimulation-industry                                    

Further key findings from the report suggest:

  • The services segment is expected to exhibit growth at a significant CAGR of over 16.0% during the forecast period. This is a consequence of rising inclination of the big pharmaceutical companies to outsource their biosimulation process so as to reduce the overall cost incurred in research and development and divert its focus toward their core capabilities.
  • The drug discovery segment is anticipated to witness an exponential CAGR of over 15.0% in the application segment. Associated benefits of biosimulation in drug discovery are anticipated to fuel the demand over the forecast period. These benefits include the elimination of potential drug failures, predict unfavorable drug interactions, and anticipate potential risks.
  • In addition to these, certain other advantages include increased drug efficacy through the evaluation of optimal synergistic combinations, enable study of the mechanistic actions of drugs, and identification ofthe most suitable dosage forms, which render the drug discovery segment a profitable zone.
  • In 2015, the pharmaceutical and biotechnology companies held a substantial share of this vertical of over 58.0% in 2015. This can be attributed to the consistent efforts of these companies to develop better medication options at a faster and cheaper rate through in silico biology techniques.
  • Likewise, the academic research applications are presumed to witness constant growth as a consequence of the presence of various academic research groups that are involved in the study of complex biological systems using computer models, such as by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
  • In 2015, North America dominated the overall biosimulation marketat over 50.0%. The presence of regulatory authorities, consistently inclined towards ensuring patient safety, is a crucial factor presumed to be responsible for the dominant market share ofthis region. Moreover, the presence of highly skilled professionals also serves as a significant growth driver.
  • The numerous collaborations amongst the leading playersthat are being undertaken to promote the incorporation of biosimulation systems are expected to be responsible for bolstering the growth inthis region. For instance, Entelos, Inc. collaborated with Bayer AG to develop novel gene-based drug targets and also with Johnson & Johnson, Inc. to optimize clinical trial designs through in silico models.
  • Some of the leading players in this industry include Certara USA, Inc., Simulation Plus, Inc., Dassault Systems SA, Rhenovia Pharma Ltd., and Evidera, Inc. These players are actively involved in initiating collaborative strategies and frequent product launches to capture a larger share of the vertical.For instance, In April 2016, Simulation Plus, Inc. launched the DDDPlus Version 5.0, invitro dissolution experiment software. This upgraded version includes improvements in functionalities of the software that enable scientists and researchers to study the behavior of different pharmaceutical dosage forms.

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it                               

Grand View Research has segmented the biosimulation marketon the basis of product, application,enduse and region:

Global Biosimulation Product Outlook (Revenue, USD Million, 2013 – 2024)

  • Software
  • Services
    • In-house Services
    • Contract Services

Global Biosimulation Application Outlook (Revenue, USD Million, 2013 – 2024)

  • Drug Development
  • Drug Discovery
  • Others

Global Biosimulation End-use Outlook (Revenue, USD Million, 2013 – 2024)

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Regulatory Authorities
  • Academic Research Institutions

Biosimulation Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

Access Press Release By Grand View Research: https://www.grandviewresearch.com/press-release/global-biosimulation-market                                                     

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

 

Virtual Reality in Healthcare Market Is Predicted To Grow Swiftly Due To The Growing Integration Of Technology & Digitalization In Healthcare Till 2025: Grand View Research, Inc.

 

The global augmented reality & virtual reality in healthcare market is expected to reach USD 5.1 billion by 2025 according to a new report by Grand View Research, Inc. The growing adoption of Augmented Reality (AR) & Virtual Reality (VR) in medical field, increasing investments in such emerging technologies, and constant developments in healthcare IT are some of the key factors responsible for growth of this market.

The market is majorly driven by applications in surgical simulations, diagnostic imaging, patient care management, rehabilitation, and health management. The application of AR & VR in training medical professionals provides them enhanced understanding of anatomy & physiology and assists in complicated surgeries that require precision, thus, resulting in reduced complications and lesser trauma. VR helps patients get over their worst fears and phobias through the exposure therapy. These technologies are also gaining significance in fitness management due to the development of various health apps that help train doctors as well as patients.

The use of these advanced technologies in live streaming of surgeries for medical education coupled with patient monitoring & pain management serves as a market opportunity and is predicted to drive the segment substantially. These new disruptive technologies have revolutionized medical field and provide an innovative approach for transforming healthcare experience. The increasing focus on streamlining medical operations along with demand for better delivery of care services are driving the growing adoption of these technologies.

Increase in number of startups has led to higher demand for investments to fund development of AR & VR technologies. The market is witnessing an increase in private investments by various investors, which is expected to boost growth further. For instance, Swiss-based startup MindMaze is a well-funded company that has raised USD 100 million from Hinduja Group for development of VR hardware & software. In addition, increased government funding and supportive initiatives are expected to drive growth.

Google-Glass_AR-platform.jpg

Browse full research report on Virtual Reality in Healthcare Market: https://www.grandviewresearch.com/industry-analysis/virtual-reality-vr-in-healthcare-market                                 

Further key findings from the report suggest:

  • The hardware segment held the majority of the revenue share in 2016 due to rise in adoption of wearable devices in healthcare
  • AR dominated the technology segment in 2016 owing to its increasing adoption in surgeries and medical training
  • North America dominated the global market for AR and VR due to greater adoption of advanced technology and sophisticated infrastructure
  • Asia Pacific AR and VR market is expected to witness a lucrative growth of 33% over the forecast period
  • Some of the key players include CAE HEALTHCARE; GE Healthcare; Intuitive Surgical; Hologic, Inc.; Virtual Realities, LLC; and Philips Healthcare

Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it                                

Grand View Research has segmented the augmented reality & virtual reality in healthcare market on the basis of component, technology and region:

Component Outlook (Revenue, USD Million, 2014 – 2025)

  • Hardware
  • Software
  • Service

Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Augmented Reality
    • Surgical Application
    • Rehabilitation
    • Training & Medical Education
  • Virtual Reality
    • Simulation
    • Diagnostics
    • Virtual Reality Exposure Therapy
    • Rehabilitation
    • Pain Distraction

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: https://www.grandviewresearch.com/press-release/global-augmented-reality-ar-virtual-reality-vr-in-healthcare-market                                                      

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com

 

Digital Pathology Market Is Predicted To Grow Swiftly Due To Growing Economic Stability Till 2025: Grand View Research, Inc.

 

The global digital pathology market is expected to reach USD 979.0 million by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases, which triggers demand for advanced diagnostics, is expected to provide growth opportunities to digital pathology market. Growing economic stability and awareness pertaining to associated benefits with the use of computer-aided diagnostics is further contributing toward the industry growth.

Technological advancements such as digital imaging, computerization, robotic light microscopy, and multiple fiberoptic communications are some of the key factors contributing toward the rising adoption of digital pathology. In addition, introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve this industry as a potential growth driver.

Digital pathology has important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is propelling the adoption of this technology over the forecast period.

This market is expected to witness intense competition in near future owing to rising adoption of rigorous strategies by the market players to sustain competition. For instance; manufacturers of whole slide imaging systems are focused on obtaining premarket approval for diagnostic digital systems to capture more revenue share.

U.S. digital pathology market revenue by technology, 2014 – 2025 (USD million)

us-digital-pathology-market.png

Browse full research report on Digital Pathology Market: http://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market                         

Further key findings from the report suggest:

  • Whole slide imaging held the dominant share as of 2016 owing to its increased use in academic research
  • Rising implementation of whole slide image scanning in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
  • Telepathology segment is expected to witness lucrative growth in the near future owing to the benefits associated with its use
  • Telepathology offers faster diagnosis and synchronizes patient data, where healthcare professionals can remotely access this information
  • Rising demand for accurate & faster diagnosis fosters the demand for static image-based systems that further contributes to the static telepathology system growth
  • Digital pathology has wide applications in academic research owing to various benefits such as cost-effectiveness and rapid results
  • The availability of unified platforms for workflows in pathology is anticipated to boost the usage rate of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it            

Grand View Research has segmented the digital pathology market on the basis of the technology, application, and region:

Digital Pathology Technology Outlook (Revenue, USD Million, 2014 – 2025)

  • Whole Slide Imaging
  • Telepathology
    • Static
    • Dynamic

Digital Pathology Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Drug Discovery & Development
  • Academic Research
  • Disease Diagnosis

Digital Pathology Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Mexico
    • Brazil
  • MEA
    • South Africa

 

Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-digital-pathology-market                            

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: http://www.grandviewresearch.com